Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Dooley

Showing results (21-30 of 310) with videos related to

Pageof 31
Sort By:
Medicine, Science, and the Law|October 1, 1987
A study of attempted suicides in prisonsR J Wool, E Dooley
The Lancet. HIV|May 25, 2023
Dolutegravir once daily with rifampicin for HIV and tuberculosisAnushka Naidoo, Kelly E Dooley
BMC Psychiatry|October 17, 2023
Positive mental health in adults with bipolar disorder: exploring social support subtypes, negative social interactions and potential to flourishKen Fowler, Kaya E Dooley
The Lancet. Respiratory Medicine|March 19, 2021
A leap forward in assessing host-directed therapies for tuberculosisElisa H Ignatius, Kelly E Dooley
Clinics in Chest Medicine|April 20, 2005
Treatment of latent tuberculosis infection: challenges and prospectsKelly E Dooley, Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Preclinical tools for the evaluation of tuberculosis treatment regimens for childrenE W Tucker, K E Dooley
Clinical Pharmacology and Therapeutics|August 24, 2018
State-of-the-Art Review of HIV-TB Coinfection in Special PopulationsEthel D Weld, Kelly E Dooley
Annual Review of Medicine|November 8, 2018
The Global Landscape of Tuberculosis TherapeuticsJeffrey A Tornheim, Kelly E Dooley
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2019
Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosisChristine Sekaggya-Wiltshire, Kelly E Dooley
Current Opinion in HIV and AIDS|August 7, 2018
Challenges of TB and HIV co-treatment: updates and insightsJeffrey A Tornheim, Kelly E Dooley
Pageof 31

Showing results (21-30 of 310) with videos related to

Sort By:
Pageof 31
Medicine, Science, and the Law|October 1, 1987
A study of attempted suicides in prisonsR J Wool, E Dooley
The Lancet. HIV|May 25, 2023
Dolutegravir once daily with rifampicin for HIV and tuberculosisAnushka Naidoo, Kelly E Dooley
BMC Psychiatry|October 17, 2023
Positive mental health in adults with bipolar disorder: exploring social support subtypes, negative social interactions and potential to flourishKen Fowler, Kaya E Dooley
The Lancet. Respiratory Medicine|March 19, 2021
A leap forward in assessing host-directed therapies for tuberculosisElisa H Ignatius, Kelly E Dooley
Clinics in Chest Medicine|April 20, 2005
Treatment of latent tuberculosis infection: challenges and prospectsKelly E Dooley, Timothy R Sterling
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 19, 2018
Preclinical tools for the evaluation of tuberculosis treatment regimens for childrenE W Tucker, K E Dooley
Clinical Pharmacology and Therapeutics|August 24, 2018
State-of-the-Art Review of HIV-TB Coinfection in Special PopulationsEthel D Weld, Kelly E Dooley
Annual Review of Medicine|November 8, 2018
The Global Landscape of Tuberculosis TherapeuticsJeffrey A Tornheim, Kelly E Dooley
Expert Opinion on Drug Metabolism & Toxicology|July 25, 2019
Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosisChristine Sekaggya-Wiltshire, Kelly E Dooley
Current Opinion in HIV and AIDS|August 7, 2018
Challenges of TB and HIV co-treatment: updates and insightsJeffrey A Tornheim, Kelly E Dooley
Pageof 31